Unresolved disorder model. using A
ATOM    829  CA ATHR   106       6.233  -4.122 -16.663  0.50 19.78           C  
Unresolved disorder model. using A
ATOM    830  CA BTHR   106       6.231  -4.123 -16.655  0.50 18.53           C  
Unresolved disorder model. using A
ATOM    833  CB ATHR   106       4.942  -3.278 -16.761  0.50 19.53           C  
Unresolved disorder model. using A
ATOM    834  CB BTHR   106       4.915  -3.269 -16.677  0.50 17.99           C  
Unresolved disorder model. using A
ATOM    835  OG1ATHR   106       4.829  -2.697 -18.077  0.50 21.53           O  
Unresolved disorder model. using A
ATOM    836  OG1BTHR   106       3.785  -4.077 -16.317  0.50 12.36           O  
Unresolved disorder model. using A
ATOM    837  CG2ATHR   106       4.954  -2.175 -15.720  0.50 19.73           C  
Unresolved disorder model. using A
ATOM    838  CG2BTHR   106       4.666  -2.620 -18.069  0.50 18.85           C  
Unresolved disorder model. using A
ATOM   1118  CA AASP   145     -10.215   3.778  -2.532  0.50 19.11           C  
Unresolved disorder model. using A
ATOM   1119  CA BASP   145     -10.277   3.766  -2.605  0.50 19.06           C  
Unresolved disorder model. using A
ATOM   1122  CB AASP   145     -10.009   4.367  -1.115  0.50 19.62           C  
Unresolved disorder model. using A
ATOM   1123  CB BASP   145     -10.371   4.385  -1.198  0.50 19.79           C  
Unresolved disorder model. using A
ATOM   1124  CG AASP   145     -10.999   5.462  -0.788  0.50 22.19           C  
Unresolved disorder model. using A
ATOM   1125  CG BASP   145     -11.427   3.703  -0.338  0.50 21.92           C  
Unresolved disorder model. using A
ATOM   1126  OD1AASP   145     -12.001   5.594  -1.523  0.50 24.35           O  
Unresolved disorder model. using A
ATOM   1127  OD1BASP   145     -12.501   3.326  -0.864  0.50 22.61           O  
Unresolved disorder model. using A
ATOM   1128  OD2AASP   145     -10.782   6.195   0.214  0.50 24.59           O-1
Unresolved disorder model. using A
ATOM   1129  OD2BASP   145     -11.184   3.542   0.870  0.50 27.41           O-1
Unresolved disorder model. using A
ATOM   1168  CA AASP   150      -9.138   8.186 -17.282  0.50 18.90           C  
Unresolved disorder model. using A
ATOM   1169  CA BASP   150      -8.963   8.162 -17.221  0.50 19.14           C  
Unresolved disorder model. using A
ATOM   1172  CB AASP   150      -7.848   8.963 -17.570  0.50 19.15           C  
Unresolved disorder model. using A
ATOM   1173  CB BASP   150      -7.464   8.520 -17.246  0.50 19.34           C  
Unresolved disorder model. using A
ATOM   1174  CG AASP   150      -7.797   9.507 -19.017  0.50 21.37           C  
Unresolved disorder model. using A
ATOM   1175  CG BASP   150      -7.108   9.687 -16.337  0.50 22.62           C  
Unresolved disorder model. using A
ATOM   1176  OD1AASP   150      -8.812   9.427 -19.750  0.50 24.56           O  
Unresolved disorder model. using A
ATOM   1177  OD1BASP   150      -7.863  10.674 -16.307  0.50 24.58           O  
Unresolved disorder model. using A
ATOM   1178  OD2AASP   150      -6.741  10.011 -19.422  0.50 25.14           O-1
Unresolved disorder model. using A
ATOM   1179  OD2BASP   150      -6.056   9.615 -15.653  0.50 25.45           O-1

1